Oppenheimer & Co’s Guardant Health GH Stock Holding History

Oppenheimer & Co’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$756K	Sell	5,036 -346	-6%	-$37.6K	0.01%	1064
2026 Q1	$497K	Buy	5,382 +20	+0.4%	+$2.01K	0.01%	1189
2025 Q4	$548K	Buy	+5,362	New	+$480K	0.01%	1041
2025 Q2	–	Sell	-10,382	Closed	-$442K	–	1644
2025 Q1	$442K	Buy	+10,382	New	+$448K	0.01%	1113
2021 Q1	–	Sell	-1,651	Closed	-$213K	–	1468
2020 Q4	$213K	Buy	+1,651	New	+$190K	﹤0.01%	1223

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Oppenheimer & Co's GH Position: Q2 2026 in Review

Oppenheimer & Co reduced its Guardant Health (GH) stake by 6.4% in Q2 2026, selling an estimated $37.6K and leaving 5,036 shares worth $756K. The position accounts for 0.01% of the portfolio, ranked #1064.

Oppenheimer & Co first reported a position in GH in Q4 2020 and has held it in 5 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Oppenheimer & Co held 5,036 shares of Guardant Health worth $756K as of Q2 2026.
Oppenheimer & Co sold 346 Guardant Health shares in Q2 2026, an estimated $37.6K.
Guardant Health made up 0.01% of Oppenheimer & Co's portfolio in Q2 2026, its #1064 holding.
Oppenheimer & Co first reported a position in Guardant Health in Q4 2020 and has held it in 5 quarters since.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.